Solstice Oncology
A clinical-stage immunotherapy company is advancing an engineered CTLA-4 antibody for earlier cancer treatment.
$225MSeries A
ParticipantCP
Canaan Partners
Activity from announced rounds
Activity in this selectionadbio-c4f34d9f
- Rounds participated in
- 8
- Confirmed lead rounds
- 0 7 roles undisclosed
- New companies
- 8 First participation on record · 0 follow-on
- Funding in participating rounds
- $765.5M 8 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
8 in this selectionActualyze AI
An enterprise gateway for AI-model access, request security, budgets and routing.
$7MSeed
Role not disclosedDraig Therapeutics
Developing transformative, best-in-class neuropsychiatric therapies
$65MSeries B
Role not disclosedVedana Therapeutics
Develops next-generation therapies for migraine prevention
$46MSeries A
Role not disclosedHeyMilo AI
Builds agentic recruiting platform that screens high-volume candidates via voice, video, SMS, and resume agents
$6MSeed
Role not disclosedSageOx
Builds shared context infrastructure for AI-native teams
$15MSeed
Role not disclosedHermeus
Develops high-Mach unmanned aircraft for national security missions
$350MSeries C
Role not disclosedNovee
Provides AI-powered penetration testing platform to secure environments against AI-driven cyberat...
$51.5MSeries A
Role not disclosed